



| Three Months Ended June 30, | ||||||||||||||
| (in millions, except per share data) | 2026 | 2025 | ||||||||||||
| Net sales | $ | 3,929 | $ | 3,741 | ||||||||||
| Cost of sales | 3,694 | 3,504 | ||||||||||||
| Gross profit | 235 | 237 | ||||||||||||
| Selling, general and administrative expenses | 136 | 129 | ||||||||||||
| Restructuring and impairment costs | 5 | 7 | ||||||||||||
| Equity income | 20 | 17 | ||||||||||||
| Earnings before interest and income taxes | 114 | 118 | ||||||||||||
| Net financing charges | 48 | 51 | ||||||||||||
| Other pension expense | 1 | 1 | ||||||||||||
| Income before income taxes | 65 | 66 | ||||||||||||
| Income tax provision | 23 | 7 | ||||||||||||
| Net income | 42 | 59 | ||||||||||||
| Income attributable to noncontrolling interests | 17 | 23 | ||||||||||||
| Net income attributable to Adient | $ | 25 | $ | 36 | ||||||||||
| Diluted earnings per share | $ | 0.32 | $ | 0.43 | ||||||||||
| Shares outstanding at period end | 77.1 | 81.2 | ||||||||||||
| Diluted weighted average shares | 79.2 | 83.7 | ||||||||||||
| June 30, | September 30, | |||||||||||||
| (in millions) | 2026 | 2025 | ||||||||||||
| Assets | ||||||||||||||
| Cash and cash equivalents | $ | 924 | $ | 958 | ||||||||||
Accounts receivable - net | 1,881 | 1,873 | ||||||||||||
| Inventories | 729 | 695 | ||||||||||||
| Other current assets | 652 | 607 | ||||||||||||
| Current assets | 4,186 | 4,133 | ||||||||||||
| Property, plant and equipment - net | 1,385 | 1,409 | ||||||||||||
| Goodwill | 1,799 | 1,807 | ||||||||||||
| Other intangible assets - net | 298 | 319 | ||||||||||||
| Investments in partially-owned affiliates | 276 | 276 | ||||||||||||
| Assets held for sale | 12 | 9 | ||||||||||||
| Other noncurrent assets | 1,003 | 1,001 | ||||||||||||
| Total assets | $ | 8,959 | $ | 8,954 | ||||||||||
| Liabilities and Shareholders' Equity | ||||||||||||||
| Short-term debt | $ | 9 | $ | 11 | ||||||||||
| Accounts payable and accrued expenses | 3,122 | 2,942 | ||||||||||||
| Other current liabilities | 685 | 734 | ||||||||||||
| Current liabilities | 3,816 | 3,687 | ||||||||||||
| Long-term debt | 2,379 | 2,386 | ||||||||||||
| Other noncurrent liabilities | 676 | 723 | ||||||||||||
| Redeemable noncontrolling interests | 75 | 95 | ||||||||||||
| Shareholders' equity attributable to Adient | 1,729 | 1,766 | ||||||||||||
| Noncontrolling interests | 284 | 297 | ||||||||||||
| Total liabilities and shareholders' equity | $ | 8,959 | $ | 8,954 | ||||||||||
| Three Months Ended June 30, | ||||||||||||||
| (in millions) | 2026 | 2025 | ||||||||||||
| Operating Activities | ||||||||||||||
| Net income attributable to Adient | $ | 25 | $ | 36 | ||||||||||
| Income attributable to noncontrolling interests | 17 | 23 | ||||||||||||
| Net income | 42 | 59 | ||||||||||||
| Adjustments to reconcile net income to cash provided by operating activities: | ||||||||||||||
| Depreciation | 74 | 71 | ||||||||||||
| Amortization of intangibles | 12 | 12 | ||||||||||||
| Pension and postretirement benefit expense | 2 | 2 | ||||||||||||
| Pension and postretirement contributions, net | (8) | (2) | ||||||||||||
| Equity in earnings of partially-owned affiliates, net of dividends received | 30 | 2 | ||||||||||||
| Deferred income taxes | (15) | (16) | ||||||||||||
| Equity-based compensation | 9 | 10 | ||||||||||||
| Other | — | (5) | ||||||||||||
| Changes in assets and liabilities: | ||||||||||||||
| Receivables | 113 | 117 | ||||||||||||
| Inventories | 7 | 20 | ||||||||||||
| Other assets | 64 | (62) | ||||||||||||
| Accounts payable and accrued liabilities | (133) | (28) | ||||||||||||
| Accrued income taxes | 8 | (8) | ||||||||||||
| Cash provided by operating activities | 205 | 172 | ||||||||||||
| Investing Activities | ||||||||||||||
| Capital expenditures | (67) | (57) | ||||||||||||
| Sale of property, plant and equipment | 6 | 8 | ||||||||||||
| Settlement of derivatives | 3 | — | ||||||||||||
| Business acquisitions | (4) | — | ||||||||||||
| Cash used by investing activities | (62) | (49) | ||||||||||||
| Financing Activities | ||||||||||||||
| Drawdown of ABL revolver and other bank borrowings | 3 | — | ||||||||||||
| Repayment of ABL revolver and other bank borrowings | (3) | (2) | ||||||||||||
| Repayment of long-term debt | (2) | (2) | ||||||||||||
| Share repurchases | (30) | (50) | ||||||||||||
| Dividends paid to noncontrolling interests | (10) | (9) | ||||||||||||
| Cash used by financing activities | (42) | (63) | ||||||||||||
| Effect of exchange rate changes on cash and cash equivalents | (8) | 46 | ||||||||||||
| Increase in cash and cash equivalents | $ | 93 | $ | 106 | ||||||||||
| (in millions) | Three months ended June 30, 2026 | |||||||||||||||||||||||||||||||
| Americas | EMEA | Asia | Corporate/Eliminations | Consolidated | ||||||||||||||||||||||||||||
| Net sales | $ | 1,928 | $ | 1,211 | $ | 810 | $ | (20) | $ | 3,929 | ||||||||||||||||||||||
| Adjusted EBITDA | $ | 125 | $ | 14 | $ | 107 | $ | (21) | $ | 225 | ||||||||||||||||||||||
| Adjusted EBITDA margin | 6.5 | % | 1.2 | % | 13.2 | % | N/A | 5.7 | % | |||||||||||||||||||||||
| Three months ended June 30, 2025 | ||||||||||||||||||||||||||||||||
| Americas | EMEA | Asia | Corporate/Eliminations | Consolidated | ||||||||||||||||||||||||||||
| Net sales | $ | 1,760 | $ | 1,268 | $ | 721 | $ | (8) | $ | 3,741 | ||||||||||||||||||||||
| Adjusted EBITDA | $ | 112 | $ | 21 | $ | 113 | $ | (20) | $ | 226 | ||||||||||||||||||||||
| Adjusted EBITDA margin | 6.4 | % | 1.7 | % | 15.7 | % | N/A | 6.0 | % | |||||||||||||||||||||||
| Three Months Ended June 30, | ||||||||||||||
| (in millions) | 2026 | 2025 | ||||||||||||
| Adjusted EBITDA | ||||||||||||||
| Americas | $ | 125 | $ | 112 | ||||||||||
| EMEA | 14 | 21 | ||||||||||||
| Asia | 107 | 113 | ||||||||||||
| Subtotal | 246 | 246 | ||||||||||||
Corporate-related costs (1) | (21) | (20) | ||||||||||||
Restructuring and impairment costs (2) | (5) | (7) | ||||||||||||
Purchase accounting amortization (3) | (12) | (12) | ||||||||||||
Restructuring related activities (4) | (8) | (7) | ||||||||||||
| Equity based compensation | (9) | (10) | ||||||||||||
| Depreciation | (74) | (71) | ||||||||||||
Other items (5) | (3) | (1) | ||||||||||||
| Earnings before interest and income taxes | $ | 114 | $ | 118 | ||||||||||
| Net financing charges | (48) | (51) | ||||||||||||
| Other pension expense | (1) | (1) | ||||||||||||
| Income before income taxes | $ | 65 | $ | 66 | ||||||||||
| Three Months Ended June 30, | ||||||||||||||
| (in millions, except per share data) | 2026 | 2025 | ||||||||||||
| Income available to shareholders | ||||||||||||||
| Net income attributable to Adient | $ | 25 | $ | 36 | ||||||||||
| Weighted average shares outstanding | ||||||||||||||
| Basic weighted average shares outstanding | 78.1 | 83.5 | ||||||||||||
| Effect of dilutive securities: | ||||||||||||||
| Unvested restricted stock and unvested performance share awards | 1.1 | 0.2 | ||||||||||||
| Diluted weighted average shares outstanding | 79.2 | 83.7 | ||||||||||||
| Earnings per share: | ||||||||||||||
| Basic | $ | 0.32 | $ | 0.43 | ||||||||||
| Diluted | $ | 0.32 | $ | 0.43 | ||||||||||
| (a) | Adjusted EBIT is defined as earnings before income taxes and noncontrolling interests excluding net financing charges, restructuring, impairment and related costs, purchase accounting amortization, transaction gains/losses, other significant non-recurring items, and net mark-to-market adjustments on pension and postretirement plans. Adjusted EBIT margin is adjusted EBIT as a percentage of net sales. | ||||
| (b) | Adjusted EBITDA is defined as adjusted EBIT excluding depreciation and equity based compensation. Certain corporate-related costs are not allocated to the business segments in determining adjusted EBITDA. Adjusted EBITDA margin is adjusted EBITDA as a percentage of net sales. | ||||
| (c) | Adjusted net income attributable to Adient is defined as net income (loss) attributable to Adient excluding restructuring, impairment and related costs, purchase accounting amortization, transaction gains/losses, other significant non-recurring items, net mark-to-market adjustments on pension and postretirement plans, the tax impact of these items and other discrete tax charges/benefits. | ||||
| (d) | Adjusted income tax expense is defined as income tax expense adjusted for the tax effect of the adjustments to income before income taxes and other discrete tax changes/benefits. Adjusted effective tax rate is defined as adjusted income tax provision as a percentage of adjusted income before income taxes. | ||||
| (e) | Adjusted diluted earnings per share is defined as adjusted net income attributable to Adient divided by diluted weighted average shares. | ||||
| (f) | Adjusted equity income is defined as equity income excluding amortization of Adient's intangible assets related to its non-consolidated joint ventures and other unusual or non-recurring items impacting equity income. | ||||
| (g) | Adjusted interest expense is defined as net financing charges excluding unusual or one-time items impacting interest expense. | ||||
| (h) | Free cash flow is defined as cash provided by operating activities less capital expenditures. | ||||
| (i) | Net debt is calculated as total debt (short-term and long-term) less cash and cash equivalents. | ||||
| (j) | Net leverage ratio is calculated as net debt divided by adjusted EBITDA for the last four quarters. | ||||
| Three Months Ended June 30, | ||||||||||||||
| (in millions) | 2026 | 2025 | ||||||||||||
| Net income | $ | 42 | $ | 59 | ||||||||||
| Net financing charges | 48 | 51 | ||||||||||||
| Other pension expense | 1 | 1 | ||||||||||||
| Income tax expense | 23 | 7 | ||||||||||||
| Earnings before interest and income taxes (EBIT) | $ | 114 | $ | 118 | ||||||||||
| EBIT adjustments: | ||||||||||||||
Restructuring and impairment costs (2) | 5 | 7 | ||||||||||||
Purchase accounting amortization (3) | 12 | 12 | ||||||||||||
Restructuring related activities (4) | 8 | 7 | ||||||||||||
Other items (5) | 3 | 1 | ||||||||||||
| EBIT adjustments total | 28 | 27 | ||||||||||||
| Adjusted EBIT | $ | 142 | $ | 145 | ||||||||||
| EBITDA adjustments: | ||||||||||||||
| Depreciation | 74 | 71 | ||||||||||||
| Equity based compensation | 9 | 10 | ||||||||||||
| Adjusted EBITDA | $ | 225 | $ | 226 | ||||||||||
| Net sales | $ | 3,929 | $ | 3,741 | ||||||||||
| Net income as % of net sales | 1.1 | % | 1.6 | % | ||||||||||
| EBIT as % of net sales | 2.9 | % | 3.2 | % | ||||||||||
| Adjusted EBIT as % of net sales | 3.6 | % | 3.9 | % | ||||||||||
| Adjusted EBITDA as % of net sales | 5.7 | % | 6.0 | % | ||||||||||
| Three Months Ended June 30, | ||||||||||||||
| (in millions) | 2026 | 2025 | ||||||||||||
| Net income attributable to Adient | $ | 25 | $ | 36 | ||||||||||
| Net income adjustments: | ||||||||||||||
| EBIT adjustments total - see table (a) & (b) | 28 | 27 | ||||||||||||
| Tax impact of EBIT adjustments and other tax items - see table (d) | (13) | (23) | ||||||||||||
Impact of adjustments on noncontrolling interests (6) | (2) | (2) | ||||||||||||
| Net income adjustments total | 13 | 2 | ||||||||||||
| Adjusted net income attributable to Adient | $ | 38 | $ | 38 | ||||||||||
| Three months ended June 30, | ||||||||||||||||||||||||||||||||||||||
| 2026 | 2025 | |||||||||||||||||||||||||||||||||||||
| (in millions, except effective tax rate) | Income before income taxes | Income tax expense (benefit) | Effective tax rate | Income before income taxes | Income tax expense (benefit) | Effective tax rate | ||||||||||||||||||||||||||||||||
| As reported | $ | 65 | $ | 23 | 35.4 | % | $ | 66 | $ | 7 | 10.6 | % | ||||||||||||||||||||||||||
| Adjustments | ||||||||||||||||||||||||||||||||||||||
| EBIT adjustments - see table (a) & (b) | 28 | 3 | 10.7 | % | 27 | 1 | 3.7 | % | ||||||||||||||||||||||||||||||
| Tax audit closures and statute expirations | — | (1) | nm | — | 16 | nm | ||||||||||||||||||||||||||||||||
| UTP establishments and interest | — | (3) | nm | — | (1) | nm | ||||||||||||||||||||||||||||||||
| Intellectual property rights transfer | — | 11 | nm | — | — | nm | ||||||||||||||||||||||||||||||||
| FX remeasurements of tax balances | — | 3 | nm | — | 7 | nm | ||||||||||||||||||||||||||||||||
| Subtotal of adjustments | 28 | 13 | 46.4 | % | 27 | 23 | 85.2 | % | ||||||||||||||||||||||||||||||
| As adjusted | $ | 93 | $ | 36 | 38.7 | % | $ | 93 | $ | 30 | 32.3 | % | ||||||||||||||||||||||||||
| Three Months Ended June 30, | ||||||||||||||
| (in millions, except per share data) | 2026 | 2025 | ||||||||||||
| Numerator: | ||||||||||||||
| Adjusted net income attributable to Adient - see table (c) | $ | 38 | $ | 38 | ||||||||||
| Denominator: | ||||||||||||||
| Basic weighted average shares outstanding | 78.1 | 83.5 | ||||||||||||
| Effect of dilutive securities: | ||||||||||||||
| Unvested restricted stock and unvested performance share awards | 1.1 | 0.2 | ||||||||||||
| Diluted weighted average shares outstanding | 79.2 | 83.7 | ||||||||||||
| Adjusted diluted earnings per share | $ | 0.48 | $ | 0.45 | ||||||||||
| Three Months Ended June 30, | ||||||||||||||
| 2026 | 2025 | |||||||||||||
| Diluted earnings per share as reported | $ | 0.32 | $ | 0.43 | ||||||||||
| EBIT adjustments total | 0.35 | 0.31 | ||||||||||||
| Tax impact of EBIT adjustments and other tax items | (0.16) | (0.27) | ||||||||||||
| Impact of adjustments on noncontrolling interests | (0.03) | (0.02) | ||||||||||||
| Adjusted diluted earnings per share | $ | 0.48 | $ | 0.45 | ||||||||||
| Three Months Ended June 30, | ||||||||||||||
| (in millions) | 2026 | 2025 | ||||||||||||
| Equity income | $ | 20 | $ | 17 | ||||||||||
| Equity income adjustments: | ||||||||||||||
| Restructuring charges at affiliates | — | 6 | ||||||||||||
| Equity income adjustments total | — | 6 | ||||||||||||
| Adjusted equity income | $ | 20 | $ | 23 | ||||||||||
| Three Months Ended June 30, | ||||||||||||||
| (in millions) | 2026 | 2025 | ||||||||||||
| Net financing charges | $ | 48 | $ | 51 | ||||||||||
| Interest expense adjustments: | ||||||||||||||
| None | — | — | ||||||||||||
| Interest expense adjustments total | — | — | ||||||||||||
| Adjusted net financing charges | $ | 48 | $ | 51 | ||||||||||
| Three Months Ended June 30, | Nine Months Ended June 30, | |||||||||||||||||||||||||
| (in millions) | 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||||
| Operating cash flow | $ | 205 | $ | 172 | $ | 366 | $ | 236 | ||||||||||||||||||
| Capital expenditures | (67) | (57) | (205) | (166) | ||||||||||||||||||||||
| Free cash flow | $ | 138 | $ | 115 | $ | 161 | $ | 70 | ||||||||||||||||||
| Three Months Ended June 30, | Nine Months Ended June 30, | |||||||||||||||||||||||||
| (in millions) | 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||||
| Adjusted EBITDA | $ | 225 | $ | 226 | $ | 655 | $ | 655 | ||||||||||||||||||
| Adjusted equity income | (20) | (23) | (63) | (63) | ||||||||||||||||||||||
| Dividends from partially owned affiliates | 50 | 20 | 78 | 72 | ||||||||||||||||||||||
| Restructuring (cash) | (39) | (34) | (77) | (101) | ||||||||||||||||||||||
| Working capital | 145 | 108 | 105 | (38) | ||||||||||||||||||||||
| Interest paid | (53) | (55) | (150) | (142) | ||||||||||||||||||||||
| Cash taxes | (30) | (31) | (104) | (70) | ||||||||||||||||||||||
| Other | (73) | (39) | (78) | (77) | ||||||||||||||||||||||
| Capital expenditures | (67) | (57) | (205) | (166) | ||||||||||||||||||||||
| Free cash flow | $ | 138 | $ | 115 | $ | 161 | $ | 70 | ||||||||||||||||||
| June 30, | September 30, | |||||||||||||
| (in millions) | 2026 | 2025 | ||||||||||||
| Numerator: | ||||||||||||||
| Short-term debt | $ | — | $ | 2 | ||||||||||
| Current portion of long-term debt | 9 | 9 | ||||||||||||
| Long-term debt | 2,379 | 2,386 | ||||||||||||
| Total debt | 2,388 | 2,397 | ||||||||||||
| Less: cash and cash equivalents | 924 | 958 | ||||||||||||
| Net debt | $ | 1,464 | $ | 1,439 | ||||||||||
| Denominator: | ||||||||||||||
| Adjusted EBITDA - last four quarters | ||||||||||||||
| Q1 2025 | na | $ | 196 | |||||||||||
| Q2 2025 | na | 233 | ||||||||||||
| Q3 2025 | na | 226 | ||||||||||||
| Q4 2025 | 226 | 226 | ||||||||||||
| Q1 2026 | 207 | na | ||||||||||||
| Q2 2026 - see table (a) & (b) | 223 | na | ||||||||||||
| Q3 2026 | 225 | na | ||||||||||||
| Last four quarters | $ | 881 | $ | 881 | ||||||||||
| Net leverage ratio | 1.66 | 1.63 | ||||||||||||
| Three Months Ended June 30, | ||||||||||||||
| (in millions) | 2026 | 2025 | ||||||||||||
| Restructuring related charges | $ | (8) | $ | (7) | ||||||||||
| Restructuring charges at affiliates | — | (6) | ||||||||||||
| Gain of sale of a restructured facility | — | 6 | ||||||||||||
| $ | (8) | $ | (7) | |||||||||||
| Three Months Ended June 30, | ||||||||||||||
| (in millions) | 2026 | 2025 | ||||||||||||
| Transaction costs | $ | (3) | $ | (1) | ||||||||||